FDA OKs Pfizer’s Lyrica to Treat Neuropathic Pain Due to Spinal Cord Injury
The FDA has approved an expanded indication for Pfizer’s Lyrica CV to treat neuropathic pain due to spinal cord injury, boosting the pharma giant’s fast-growing pain management portfolio.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.